Latest Bayer AG Stories
WHIPPANY, N.J., Feb. 9, 2015 /PRNewswire/ -- More than 700,000 people suffer heart attacks and 795,000 people have a stroke each year in the United States.
Three UCSF researchers are partnering with Bayer HealthCare in this unique academic-industry collaboration SAN FRANCISCO, Jan.
Multidistrict Litigation For Xarelto Bleeding Lawsuits That Allege Patients Experienced Uncontrollable Bleeding And Other Complications After Taking The Prescription Blood Thinner Has Been Established
A Request To Centralize Xarelto Lawsuits Alleging Xarelto Users Experience Uncontrolled Bleeding Due To Taking The Blood Thinner Is Under Consideration By the U.S.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
Xarelto Page Launched to Monitor Lawsuits Being Filed on Behalf of Patients Who Allege the Blood Thinner Causes Severe Internal Bleeding and Uncontrollable Bleeding New
DUBLIN, November 4, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dk8mkw/micro_market) has announced the addition of the "Micro
Award recognizes innovation that enhances the role of produce in creating better lives ANAHEIM, Calif., Oct.
-- Bayer becomes the OTC leader in North and Latin America and achieves top global positions in key OTC categories -- Erica Mann heads Bayer's new consumer care business globally
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.